CXCL9 as a Reliable Biomarker for Discriminating Anti–IFN-γ-Autoantibody–Associated Lymphadenopathy that Mimics Lymphoma

Microfluidic finger-actuated mixer for ultrasensitive electrochemical measurements of protein biomarkers for point-of-care testing

“…1A), enabling its use in resource-limited settings. The functionality of this platform was evaluated by measuring CXCL9, a serological biomarker for autoimmune and inflammatory diseases, 23–28 in spiked human plasma samples, which could be detected at concentrations as low as 4.7 pg mL −1 in <25 min, making it a promising diagnostic tool for point-of-care testing.…”